IP Library › Granted Patent US 12,618,061
Granted Patent B2
US 12,618,061 · App. 17/816,215 · Granted May 5, 2026

Methods of gene assembly using DNAzymes and use in DNA data storage

Inventors: Gemma Roselle Mendonsa (Edina, MN); Walter R. Eppler (Cranberry Township, PA)
Assignee: SEAGATE TECHNOLOGY LLC
C12N15/1031C12N15/113G11C13/0019C12N2310/127C12N2330/31G11C11/54
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,618,061
App. No.
17/816,215
Granted
May 5, 2026
Kind
B2
Abstract

Building DNA strands at a high rate that are suitable for data storage. Methods include using DNAzyme and utilizing libraries of pre-prepared oligos. A system for the DNA strand synthesis includes: a DNA symbol library comprising a number of single strand oligo symbols; a DNA linker library comprising a first set of single strand oligo linkers and a second set of single strand oligo linkers; and a DNAzyme library comprising a number of DNAzymes. An S1 end of a first DNAzyme is adapted to join the S1 end of a symbol and an S2 end of the first DNAzyme is adapted to join an S2 end of a first linker, and an S1 end of a second DNAzyme is adapted to join an S1 end of a second linker and an S2 end of the second DNAzyme is adapted to join an S2 end of the symbol.

Claims (39)

1 . A system for DNA synthesis, comprising:

a DNA symbol library comprising a number of single strand oligo symbols, each symbol having an activated 3′-phosphorimidazolide S1 end and a 5′-hydroxyl S2 end;

a DNA linker library comprising a first set of single strand oligo linkers each having a 3′-phosphorimidazolide S1 end and a 5′-hydroxyl S2 end, and a second set of single strand oligo linkers each having an activated 3′-phosphorimidazolide S1 end and a 5′-hydroxyl S2 end; and

a DNAzyme library comprising a number of DNA ligating DNAzymes, each DNA ligating DNAzyme having a 3′-phosphorimidazolide complementary S1 end and a 5′-hydroxyl complementary S2 end;

wherein each of the linkers has a sequence specificity for the DNA ligating DNAzymes, and one or both of the S1 end and the S2 end of each of the linkers hybridizes to a complementary one of the DNA ligating DNAzymes;

and wherein:

the S1 end of a first DNA ligating DNAzyme joins the S1 end of a symbol and the S2 end of the first DNA ligating DNAzyme joins the S2 end of a first linker, and

the S1 end of a second DNA ligating DNAzyme joins the S1 end of a second linker and the S2 end of the second DNA ligating DNAzyme joins the S2 end of the symbol.

2 . The system of claim 1 , wherein the symbols comprise a base section having four to eight nucleotides, and a 3′-phosphorimidazolide S1 end section and a 5′-hydroxyl S2 end section each having six to ten nucleotides, independently.

3 . The system of claim 2 , wherein the symbols comprise two joined nibbles, each nibble having a base sub-section and an end section.

4 . The system of claim 1 , wherein the linkers comprise six to twenty nucleotides.

5 . The system of claim 1 , wherein the DNA ligating DNAzymes are E47 DNAzymes.

6 . A system for DNA synthesis, comprising:

a first DNA symbol library comprising a number of single strand oligo first nibble symbols, each first nibble symbol having a base section and a 3′-phosphorimidazolide S1 end;

a second DNA symbol library comprising a number of single strand oligo second nibble symbols, each second nibble symbol having a base section and a 5′-hydroxyl S2 end;

a DNA linker library comprising a first set of single strand oligo linkers each having a 3′-phosphorimidazolide S1 end and a 5′-hydroxyl S2 end, and a second set of single strand oligo linkers each having a 3′-phosphorimidazolide S1 end and a 5′-hydroxyl S2 end; and

a DNAzyme library comprising a number of DNA ligating DNAzymes, each DNA ligating DNAzyme having a 3′-phosphorimidazolide complementary S1 end and a 5′-hydroxyl complementary S2 end;

wherein:

wherein each of the linkers has a sequence specificity for the DNA ligating DNAzymes, and one or both of the S1 end and the S2 end of each of the linkers hybridizes to a complementary one of the DNA ligating DNAzymes;

the base section of a first nibble symbol joins the base section of a second nibble symbol;

the S1 end of a first DNA ligating DNAzyme joins the S1 end of one of the first nibble symbols and the S2 end of the first DNA ligating DNAzyme joins the S2 end of a first linker, and

the S1 end of a second DNA ligating DNAzyme joins the S1 end of a second linker and the S2 end of the second DNA ligating DNAzyme joins the S2 end of one of the second nibble symbols.

7 . The system of claim 6 , wherein the first nibble symbols and the second nibble symbols have combined base sections having four to eight nucleotides, the first nibble symbol has a 3′-phosphorimidazolide S1 end section having six to ten nucleotides, and the second nibble symbol has a 5′-hydroxyl S2 end section each having six to ten nucleotides.

8 . The system of claim 6 , wherein the linkers comprise six to twenty nucleotides.

9 . The system of claim 6 , wherein, combined, the first DNA symbol library and the second DNA symbol library has 256 nibbles.

10 . A method of making a DNA strand, comprising:

providing a DNA symbol library comprising a number of single strand DNA oligo symbols, each symbol having a 3′-phosphorimidazolide S1 end and a 5′-hydroxyl S2 end;

providing a DNA linker library comprising a first set of single strand DNA oligo linkers having a 3′-phosphorimidazolide S1 end and a second set of single strand DNA oligo linkers having a 5′-hydroxyl S2 end, wherein each of the linkers has a sequence specificity for the DNA ligating DNAzymes, and one or both of the S1 end and the S2 end of each of the linkers hybridizes to a complementary one of the DNA ligating DNAzymes;

providing a DNAzyme comprising a number of DNA ligating DNAzymes having a 3′-phosphorimidazolide complementary S1 end and a 5′-hydroxyl complementary S2 end;

joining the S1 end of a first DNA ligating DNAzyme to the S1 end of a symbol and the S2 end of the first DNA ligating DNAzyme to the S2 end of a first linker; and

joining the S1 end of a second DNA ligating DNAzyme to the S1 end of a second linker and the S2 end of the second DNA ligating DNAzyme to the S2 end of the symbol.

11 . The method of claim 10 , wherein:

joining the S1 end of a first DNA ligating DNAzyme to the S1 end of a symbol and the S2 end of the first DNA ligating DNAzyme to the S2 end of a first linker; and

joining the S1 end of a second DNA ligating DNAzyme to the S1 end of a second linker and the S2 end of the second DNA ligating DNAzyme to the S2 end of the symbol, are done simultaneously.

12 . The method of claim 10 , further comprising joining the DNA strand made in claim 10 with a second DNA strand.

13 . The method of claim 12 , wherein joining the DNA strand made in claim 10 with the second DNA strand is via an enzyme assembly.

14 . The method of claim 12 , wherein joining the DNA strand made in claim 10 with the second DNA strand is via another DNA ligating DNAzyme.

15 . The method of claim 1 , wherein the DNA ligating DNAzymes are E47 DNAzymes.

16 . The system of claim 1 , wherein the DNA ligating DNAzymes are E47 DNAzymes.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2022
From: MENDONSA, GEMMA ROSELLE; EPPLER, WALTER R.
To: SEAGATE TECHNOLOGY LLC
Reel/Frame 060675/0285 →
Continuity (1)
Related Publication 20240035018A1 · Feb 1, 2024
References Cited (13)
US 10370246B1 · Milenkovic · 2019 [cited by examiner]
US 10417457B2 · Peck · 2019 [cited by applicant]
US 10460220B2 · Church · 2019 [cited by applicant]
US 11066661B2 · Rausch et al. · 2021 [cited by applicant]
US 20110099322A1 · Brownell et al. · 2011 [cited by applicant]
WO 2013178801A2 · 2013 [cited by applicant]
WO WO2019018410A1 · 2019 [cited by examiner]
Yu et al. (Insight into an Oxidative DNA-Cleaving DNAZyme: Multiple Cofactors, the Catalytic Core Map and a Highly Efficient Variant, iScience, Oct. 23, 2020) (Year: 2020). [cited by examiner]
Gu et al. (“Portable, quantitative, and sequential monitoring of copper ions and pyrophosphate based on a DNAzyme-Fe3O4 nanosystem and glucometer readout,” Analytical and Bioanalytical Chemistry, Jun. 2021) (Year: 2021). [cited by examiner]
McManus et al. (“The Structural Diversity of Deoxyribozymes”, Molecules, Sep. 6, 2010) (Year: 2010). [cited by examiner]
Xiang et al. (Expanding DNAzyme Functionality through Enzyme Cascades with Applications in Single Nucleotide Repair and Tunable DNA-Directed Assembly of Nanomaterials, Chem. Sci. , published Jan. 1, 2013) (Year: 2013). [cited by examiner]
Lindenburg et al. (“Split & mix assembly of DNA libraries for ultra-highthroughput on-bead screening of functional proteins”, Nucleic Acids Res. , published Jun. 19, 2020) (Year: 2020). [cited by examiner]
Ting et al. (Substrate specificity and kinetic framework of a DNAzyme with an expanded chemical repertoire: a putative RNaseA mimic that catalyzes RNA hydrolysis independent of a divalent metal cation, Nucleic Acids Res… [cited by examiner]